SATIO INC — Department of Health and Human Services SBIR Phase II: AH02
SATIO INC — SBIR Phase II award from Department of Health and Human Services.
- Amount
- $3,500,000
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase II
- Topic
- AH02
- Solicitation
- 75N91023R00041
- NAICS
- —
- Place of performance
- MA
- Period
- —
Description
The project plans to develop Digital SatioRx, a very low cost remotely controllable disposable microneedle transdermal drug delivery device able to deliver any liquid FDA-approved transdermal drug. Digital SatioRx's telemedicine-enabled (EHR-integrated), remotely activated, disposable design and unique delivery system will minimize infection risk and ensure administration of a reproducible drug dose to any patient in seconds. It will allow providers to ensure compliance while reducing costs and inconvenience for patients. Design features from other Satio telemedicine devices and manually operated transdermal delivery devices will guide final design.